The research for this grant consists of three sets of studies. The first will map the 5L to 3L values to produce an interim set of values applicable while international research resolves important methodological issues with the 5L approach. The EuroQol Group has similar research underway in Scotland, Poland and The Netherlands. In England, 1,000 patients will be involved who have one of four diagnoses: rheumatoid arthritis, depression, multiple sclerosis or a recent history of myocardial infarction.
The second study will focus on improving Time Trade Off (TTO) methodology, focusing on Lead and Lag Time TTO (LT-TTO). TTO helps translate EQ-5D indexes into values that can underpin health care allocation and access decisions. The research objective is to develop a better understanding of the characteristics of the data generated by LT-TTO, improve data collection tools, and provide information for selecting the particular variant of LT-TTO to be used in subsequent research.
The third study builds on the second, with the aim of investigating alternatives for addressing issues for valuation presented by the increase from 243 states under 3L to 3,125 under 5L. Specifically, a hybrid approach using LT-TTO and discrete-choice methods will be tested. This study is part of a multi-country study that also involves Argentina, China, Canada, The Netherlands, Singapore, Spain and the United States.
The research programme will yield both an interim value set for the EQ-5D-5L, and methodological improvements in approaches to valuation that can be used to produce new national value sets for use in economic evaluation.
Investigators on the grant are Prof Nancy Devlin, OHE; Dr Andrew Lloyd, Oxford Outcomes Ltd; Prof Aki Tsuchiya, University of Sheffield; and Mr Koonal Shah, OHE.
Official project title: An interim EQ-5D-5L value set for England and development of EQ-5D-5L valuation methods